Trademark applications and grants for Nabriva Therapeutics Us, Inc.. Nabriva Therapeutics Us, Inc. has 4 trademark applications. The latest application filed is for "XENLETA"
State Incorporated | DELAWARE |
Entity Type | CORPORATION |
Address | 1000 Continental Drive, Suite 600 King of Prussia, PENNSYLVANIA UNITED STATES 19406 |
Mark Image Registration | Serial | Trademark Application Date |
---|---|
"XENLETA" 88503355 |
XENLETA 2019-07-08 |
"NABRIVA THERAPEUTICS" 88488472 |
NABRIVA THERAPEUTICS 2019-06-25 |
"XENLETA" 6043681 88332586 |
XENLETA 2019-03-08 |
"CONTEPO" 87369724 |
CONTEPO 2017-03-13 |
NCAGE Code | 7F8P1 | NABRIVA THERAPEUTICS US, INC. |
CAGE Code | 7F8P1 | NABRIVA THERAPEUTICS US, INC. |
S.A.M. Registration | 7F8P1 [72863844] | NABRIVA THERAPEUTICS US, INC. |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.